The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multi-institutional outcomes of patients aged 75 years and older with pancreatic ductal adenocarcinoma treated with ablative 5-fraction stereotactic magnetic resonance image-guided adaptive radiation therapy (SMART).
 
Michael David Chuong
Employment - Fertility and IVF Center of Miami (I)
Honoraria - Sirtex Medical; Viewray
Consulting or Advisory Role - Advanced Accelerator Applications; ViewRay
Speakers' Bureau - Sirtex Medical; ViewRay
Research Funding - AstraZeneca/MedImmune; ViewRay
Travel, Accommodations, Expenses - ViewRay
 
Russell Palm
No Relationships to Disclose
 
Roberto Herrera
No Relationships to Disclose
 
Muni Rubens
No Relationships to Disclose
 
John Michael Bryant
No Relationships to Disclose
 
Sarah E. Hoffe
Stock and Other Ownership Interests - Vit Inc
Honoraria - UpToDate
Consulting or Advisory Role - Merck
Research Funding - Galera Therapeutics (Inst); Varian Medical Systems (Inst)
Patents, Royalties, Other Intellectual Property - I co-wrote the bone metastases chapter for UpToDate. They pay royalties/honoraria for that yearly.
Travel, Accommodations, Expenses - Varian Medical Systems
Other Relationship - Beyond the White Coat; Vit Inc
(OPTIONAL) Uncompensated Relationships - Galera Therapeutics; ViewRay
 
Dae Won Kim
Research Funding - Bold Therapeutics
 
Adeel Kaiser
No Relationships to Disclose
 
Antonio Ucar
No Relationships to Disclose
 
Jason B. Fleming
Leadership - Bio-Path Holdings, Inc
Consulting or Advisory Role - GlycosBio; Johnson and Johnson; Moleculin Biotech; Perthera
Patents, Royalties, Other Intellectual Property - U.S. Application No. 15/780,799, based on International Application No. PCT/US2016/065763, entitled “Polymeric Drug Delivery Systems For Treatment of Disease,” by Chun Li et al.; In the Name of Board of Regents, The University of Texas System
 
Fernando I. De Zarraga
No Relationships to Disclose
 
Pamela Joy Hodul
No Relationships to Disclose
 
Santiago Aparo
No Relationships to Disclose
 
Horacio Asbun
No Relationships to Disclose
 
Mokenge Peter Malafa
No Relationships to Disclose
 
Ramon Jimenez
No Relationships to Disclose
 
Jason Denbo
No Relationships to Disclose
 
Jessica M. Frakes
Consulting or Advisory Role - Boston Scientific